Who backs Artios?
27 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Sofinnova Partners | Venture capital |
| M Ventures | Venture capital |
| The Invus Group | PE / buyout |
| SV Health Investors | Venture capital |
| EQT Life Sciences | Venture capital |
| Pfizer Ventures | Other |
| Andera Partners | PE / buyout |
| Schroders Capital | Other |
| Novartis Venture Fund | Other |
| + 17 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for Artios
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 27 firms already write checks for companies like Artios in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.